PULMONX CORPORATION Comprehensive Income
PULMONX CORPORATION (LUNG) reported Comprehensive Income of -$10.20 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-08-04
- PULMONX CORPORATION comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-06-30 was -$10.20M.
- PULMONX CORPORATION comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-03-31 was -$13.85M.
- PULMONX CORPORATION comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-12-31 was -$10.30M.
- PULMONX CORPORATION comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-09-30 was -$14.36M.
- PULMONX CORPORATION comprehensive income (loss), net of tax, attributable to parent for fiscal 2025 was -$53.76M.
- PULMONX CORPORATION comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was -$56.92M.
- PULMONX CORPORATION comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was -$59.78M.
- PULMONX CORPORATION comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was -$59.06M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$10.20M 10-Q · filed 2026-08-04 | -$24.05M 10-Q · filed 2026-08-04 | -$34.35M derived: sum of 3 quarters · filed 2026-08-04 | -$48.70M derived: sum of 4 quarters · filed 2026-08-04 | ||
| 2026-03-31 | -$13.85M 10-Q · filed 2026-05-04 | -$24.15M derived: sum of 2 quarters · filed 2026-05-04 | -$38.50M derived: sum of 3 quarters · filed 2026-05-04 | -$53.24M derived: sum of 4 quarters · filed 2026-08-04 | ||
| 2025-12-31 | -$10.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | -$24.66M derived: sum of 2 quarters · filed 2026-03-10 | -$39.40M derived: sum of 3 quarters · filed 2026-08-04 | -$53.76M 10-K · filed 2026-03-10 | ||
| 2025-09-30 | -$14.36M 10-Q · filed 2025-11-12 | -$29.09M derived: sum of 2 quarters · filed 2026-08-04 | -$43.45M 10-Q · filed 2025-11-12 | -$57.05M derived: sum of 4 quarters · filed 2026-08-04 | ||
| 2025-06-30 | -$14.74M 10-Q · filed 2026-08-04 | -$29.10M 10-Q · filed 2026-08-04 | -$42.69M derived: sum of 3 quarters · filed 2026-08-04 | -$56.28M derived: sum of 4 quarters · filed 2026-08-04 | ||
| 2025-03-31 | -$14.36M 10-Q · filed 2026-05-04 | -$27.95M derived: sum of 2 quarters · filed 2026-05-04 | -$41.54M derived: sum of 3 quarters · filed 2026-05-04 | -$56.85M derived: sum of 4 quarters · filed 2026-05-04 | ||
| 2024-12-31 | -$13.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | -$27.18M derived: sum of 2 quarters · filed 2026-03-10 | -$42.49M derived: sum of 3 quarters · filed 2026-03-10 | -$56.92M 10-K · filed 2026-03-10 | ||
| 2024-09-30 | -$13.58M 10-Q · filed 2025-11-12 | -$28.90M derived: sum of 2 quarters · filed 2025-11-12 | -$43.33M 10-Q · filed 2025-11-12 | -$56.52M derived: sum of 4 quarters · filed 2025-11-12 | ||
| 2024-06-30 | -$15.32M 10-Q · filed 2025-08-01 | -$29.74M 10-Q · filed 2025-08-01 | -$42.93M derived: sum of 3 quarters · filed 2025-08-01 | -$57.85M derived: sum of 4 quarters · filed 2025-08-01 | ||
| 2024-03-31 | -$14.43M 10-Q · filed 2025-05-02 | -$27.62M derived: sum of 2 quarters · filed 2025-05-02 | -$42.53M derived: sum of 3 quarters · filed 2025-05-02 | -$58.59M derived: sum of 4 quarters · filed 2025-05-02 | ||
| 2023-12-31 | -$13.19M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | -$28.10M derived: sum of 2 quarters · filed 2025-02-25 | -$44.16M derived: sum of 3 quarters · filed 2025-02-25 | -$59.78M 10-K · filed 2025-02-25 | ||
| 2023-09-30 | -$14.91M 10-Q · filed 2024-11-01 | -$30.97M derived: sum of 2 quarters · filed 2024-11-01 | -$46.59M 10-Q · filed 2024-11-01 | -$60.69M derived: sum of 4 quarters · filed 2024-11-01 | ||
| 2023-06-30 | -$16.06M 10-Q · filed 2024-08-02 | -$31.67M 10-Q · filed 2024-08-02 | -$45.78M derived: sum of 3 quarters · filed 2024-08-02 | -$59.91M derived: sum of 4 quarters · filed 2024-08-02 | ||
| 2023-03-31 | -$15.62M 10-Q · filed 2024-05-03 | -$29.72M derived: sum of 2 quarters · filed 2024-05-03 | -$43.85M derived: sum of 3 quarters · filed 2024-05-03 | -$58.58M derived: sum of 4 quarters · filed 2024-05-03 | ||
| 2022-12-31 | -$14.11M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | -$28.24M derived: sum of 2 quarters · filed 2024-02-27 | -$42.96M derived: sum of 3 quarters · filed 2024-02-27 | -$59.06M 10-K · filed 2024-02-27 | ||
| 2022-09-30 | -$14.13M 10-Q · filed 2023-11-03 | -$28.86M derived: sum of 2 quarters · filed 2023-11-03 | -$44.95M 10-Q · filed 2023-11-03 | -$57.79M derived: sum of 4 quarters · filed 2023-11-03 | ||
| 2022-06-30 | -$14.73M 10-Q · filed 2023-08-04 | -$30.82M 10-Q · filed 2023-08-04 | -$43.66M derived: sum of 3 quarters · filed 2023-08-04 | -$53.78M derived: sum of 4 quarters · filed 2023-08-04 | ||
| 2022-03-31 | -$16.10M 10-Q · filed 2023-05-08 | -$28.93M derived: sum of 2 quarters · filed 2023-05-08 | -$39.05M derived: sum of 3 quarters · filed 2023-05-08 | -$51.94M derived: sum of 4 quarters · filed 2023-05-08 | ||
| 2021-12-31 | -$12.84M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$22.95M derived: sum of 2 quarters · filed 2023-03-01 | -$35.85M derived: sum of 3 quarters · filed 2023-03-01 | -$48.63M 10-K · filed 2023-03-01 | ||
| 2021-09-30 | -$10.12M 10-Q · filed 2022-11-08 | -$23.01M derived: sum of 2 quarters · filed 2022-11-08 | -$35.80M 10-Q · filed 2022-11-08 | -$45.06M derived: sum of 4 quarters · filed 2022-11-08 | ||
| 2021-06-30 | -$12.89M 10-Q · filed 2022-08-08 | -$12.31M 10-Q · filed 2021-08-10 | -$25.68M 10-Q · filed 2022-08-08 | -$24.63M 10-Q · filed 2021-08-10 | -$34.94M derived: sum of 3 quarters · filed 2022-08-08 | -$38.77M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | -$12.79M 10-Q · filed 2022-05-09 | -$12.32M 10-Q · filed 2021-05-12 | -$22.05M derived: sum of 2 quarters · filed 2022-05-09 | -$25.87M derived: sum of 3 quarters · filed 2022-05-09 | -$37.82M derived: sum of 4 quarters · filed 2022-05-09 | |
| 2020-12-31 | -$9.26M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$13.09M derived: sum of 2 quarters · filed 2022-03-01 | -$25.03M derived: sum of 3 quarters · filed 2022-03-01 | -$31.92M 10-K · filed 2022-03-01 | ||
| 2020-09-30 | -$3.83M 10-Q · filed 2021-11-09 | -$15.77M derived: sum of 2 quarters · filed 2021-11-09 | -$22.66M 10-Q · filed 2021-11-09 | -$27.42M derived: sum of 4 quarters · filed 2021-11-09 | ||
| 2020-06-30 | -$11.95M 10-Q · filed 2021-08-10 | -$18.83M 10-Q · filed 2021-08-10 | -$23.59M derived: sum of 3 quarters · filed 2021-08-10 | -$27.85M derived: sum of 4 quarters · filed 2021-08-10 | ||
| 2020-03-31 | -$6.89M 10-Q · filed 2021-05-12 | -$11.65M derived: sum of 2 quarters · filed 2021-05-12 | -$15.91M derived: sum of 3 quarters · filed 2021-05-12 | |||
| 2019-12-31 | -$4.76M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | -$9.02M derived: sum of 2 quarters · filed 2021-03-15 | -$20.66M 10-K · filed 2021-03-15 | |||
| 2019-09-30 | -$4.26M 10-Q · filed 2020-11-13 | -$15.90M 10-Q · filed 2020-11-13 | ||||
| 2018-12-31 | -$18.35M 10-K · filed 2021-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |